ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

 

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
S

Impact of Kinase Domain Mutations on Second Line Nilotinib Therapy In CML Chronic Phase – Real World Data from a Developing Country Perspective

By ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy FEATURING Shinto Francis Thekkudan
By ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy FEATURING Shinto Francis Thekkudan
0 views
November 16, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi
Brief Oral Communications (Biology)
05:24
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Impact of Kinase Domain Mutations on Second Line Nilotinib Therapy I…

Feat. S. Thekkudan
08:46
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Aberrant Methylation in Promoter Regions of CpG Islands of Multiple …

Feat. S. Guru